Click on image to see next photo.
Hair Rescue injection into balding skin of 70 year old man
results in new hair growth
70 year old man injected with the new Hair Rescue formula
3 months earlier
Note 2 things:
1) New terminal hairs sprouting all over the injected thinning area
2) The new hairs are the original dark color–NONE are gray
Dr. Hitzig Presents Hair Duplication &
Other Uses of Extracellular Matrix
19th Annual ISHRS Scientific Meeting – Anchorage (2011) – Presented on Friday/September 16, 2011, Dr. Gary Hitzig describes clinical applications of porcine urinary bladder matrix – UBM (i.e., ACell MatriStem). UBM is an extracellular matrix, FDA-approved wound healing agent being studied for its practical uses in hair restoration surgery. Use of this agent has been found to stimulate regenerative potential including angiogenesis and recruitment of stem cells.
ACell + PRP Injection results
Recently, Dr. Hitzig was invited to instruct and observer the utilization of ACell + PRPP and Hydr-Acell in Norway at the Poseiden Clinics. Above is a before (L) of a 32-year-old hair salon owner with prior hair transplantation in the temples and crown and after (R) only 3 months after ACell with PRP injection therapy.
ACell Patient Before & After Examples
*The patient’s transplant and injections were performed with ACell/PRP at Dr. Hitzig’s offices by Board Certified Plastic Surgeons under Dr. Hitzig’s Direct Supervision.
26-year-old male experiencing frontal and occipital hair loss. Patient elected to undergo ACell with saline injections (Prior to use of ACell with PRP) and postpone hair transplantation.
Follow up at 16 months.
Patient will continue to be monitored. (No future treatments scheduled currently)
Treatment: Acell + PRP
Condition: Progressive genetic hair loss. Patient did not want hair transplant surgery or oral treatment with Propecia.
Recommendation: Trial injections with Acell plus Platelet Rich Plasma (PRP)
Expectation: To possibly halt hair loss and evaluate in 6 months for future treatment or surgery.
Current evaluation: No further treatment until 1 year follow up.
Photos: (L) Before 7/13/10 & After (R) 1/18/11
Treatment: Acell + PRP
Condition: Class VI genetic hair loss pattern. Patient had previous hair transplant surgery with poor growth
Recommendation: Trial injections with Acell plus Arterial Platelet Rich Plasma (APRP)
Expectation: To possibly halt additional hair loss and thicken existing hair transplants
Current Evaluation: At 1 Year follow-up there is additional hair growth from the surrounding hair and from previous hair transplants. No apparent ongoing hair loss.
Photos: Before (L) 1/16/10, After (R) 1/15/11
View Dr. Hitzig’s presentation to the International Society of Hair Restoration Surgery on ACell and see more photos.
ACell’s patented Extracellular Matrix (ECM) products are covered by multiple 510(k) clearances and address important unmet clinical needs, providing safe, effective and therapeutic outcomes. Derived from porcine urinary bladders and referred to as UBM (urinary bladder matrix), trademarked as MatriStem™, ACell’s core technology is a naturally occurring, non-crosslinked, completely resorbable acellular biomaterial. A similar “first generation” ECM technology has been used to treat over 500,000 patients with remarkable effect. ACell’s MatriStem products are the next generation of ECM technology due to its unique characteristics featuring a basement membrane surface which is ideal for epithelial cell growth in many applications.
“We are growing new hair in prior donor scar sites as well as duplicating (growing multiple hairs from a single transplanted beard or donor hair) in the bald recipient area” states Dr. Ted Chaglassian, a Board Certified Plastic Surgeon and former Chief of Plastic Surgery at Memorial Sloan-Kettering Hospital and Attending Physician at Columbia Presbyterian Medical Center in NYC. He further states: “Where we go from here is anyone’s guess but the future of cloning growing hair has just been made a reality in the present!”
We will now be expanding the study by accepting a select few additional patients to work on using the Regenerative FDA cleared MatriStem MicroMatrix. The MatriStem MicroMatrix products are unique in that they fundamentally change healing by triggering abundant new blood vessel formation at the wound site and also recruit to that site numerous cell types, including progenitor cells, which have the potential to differentiate into numerous types of site specific tissues. During the healing process, the injured tissue is remodeled as the MatriStem product is completely resorbed, leaving new tissue where scar tissue would normally be expected, which may also include new hair!
Gary Hitzig, M.D. is a pioneer in the field of hair restoration surgery. He is the author of Help and Hope for Hair Loss, patented the Hitzig Linear Punch and has published numerous peer-reviewed articles on hair transplant techniques including Auto Cloning of Beard Hair. Dr. Hitzig has also presented new techniques at medical hair restoration symposiums around the world. You can learn more about Dr. Hitzig at www.nyhairloss.com. ACell’s technology is not limited to one market segment (e.g., wound care), but instead can serve as a core technology for treatments across a broad range of human medical conditions. For more information go to: www.acell.com
Schedule An Appointment Today!
To schedule a consultation with Dr. Prasad to determine the best procedure for you, submit the form below or call our Manhattan office at (646) 461-8547 or Garden City Long Island Office at (516) 535-9479. Our phones are open 24 Hours a Day / 7 Days a Week. Patient Financing options available for qualified candidates.